Hofseth BioCare ASA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was NOK 190.82 million compared to NOK 119.13 million a year ago. Revenue was NOK 218.51 million compared to NOK 120.45 million a year ago.

Net loss was NOK 106.68 million compared to NOK 137.39 million a year ago. Basic loss per share from continuing operations was NOK 0.27 compared to NOK 0.37 a year ago. Diluted loss per share from continuing operations was NOK 0.27 compared to NOK 0.37 a year ago.